ZA964465B - Use of alendronate for the prevention of osteoporosis - Google Patents

Use of alendronate for the prevention of osteoporosis

Info

Publication number
ZA964465B
ZA964465B ZA964465A ZA964465A ZA964465B ZA 964465 B ZA964465 B ZA 964465B ZA 964465 A ZA964465 A ZA 964465A ZA 964465 A ZA964465 A ZA 964465A ZA 964465 B ZA964465 B ZA 964465B
Authority
ZA
South Africa
Prior art keywords
alendronate
osteoporosis
prevention
Prior art date
Application number
ZA964465A
Other languages
English (en)
Inventor
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA964465B publication Critical patent/ZA964465B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA964465A 1995-06-02 1996-05-31 Use of alendronate for the prevention of osteoporosis ZA964465B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
ZA964465B true ZA964465B (en) 1996-12-11

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964465A ZA964465B (en) 1995-06-02 1996-05-31 Use of alendronate for the prevention of osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (zh)
JP (1) JPH10506648A (zh)
KR (1) KR19990022436A (zh)
CN (1) CN1192685A (zh)
AU (1) AU709196B2 (zh)
BG (1) BG63103B1 (zh)
BR (1) BR9609020A (zh)
CA (1) CA2222318A1 (zh)
CZ (1) CZ381197A3 (zh)
EA (1) EA000677B1 (zh)
EE (1) EE03306B1 (zh)
HU (1) HUP9900659A3 (zh)
IL (1) IL118422A0 (zh)
IS (1) IS4617A (zh)
NO (1) NO975527D0 (zh)
NZ (1) NZ308935A (zh)
PL (1) PL323669A1 (zh)
SK (1) SK159597A3 (zh)
TR (1) TR199701482T1 (zh)
WO (1) WO1996038156A1 (zh)
ZA (1) ZA964465B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
PT1392325E (pt) * 2001-05-02 2006-10-31 Novartis Ag Metodo de administracao de bifosfonatos por inalacao no tratamento ou na prevencao da reabsorcao ossea e da osteoporose
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
CA2222318A1 (en) 1996-12-05
AU5882496A (en) 1996-12-18
NO975527L (no) 1997-12-01
NZ308935A (en) 2000-07-28
IS4617A (is) 1997-11-19
AU709196B2 (en) 1999-08-26
KR19990022436A (ko) 1999-03-25
SK159597A3 (en) 1998-06-03
EP0828496A1 (en) 1998-03-18
HUP9900659A2 (hu) 2001-04-28
BR9609020A (pt) 1999-07-06
BG102060A (en) 1998-07-31
BG63103B1 (bg) 2001-04-30
CN1192685A (zh) 1998-09-09
HUP9900659A3 (en) 2002-12-28
TR199701482T1 (xx) 1998-03-21
PL323669A1 (en) 1998-04-14
EA000677B1 (ru) 2000-02-28
CZ381197A3 (cs) 1998-06-17
NO975527D0 (no) 1997-12-01
IL118422A0 (en) 1996-09-12
JPH10506648A (ja) 1998-06-30
WO1996038156A1 (en) 1996-12-05
EE03306B1 (et) 2000-12-15
EA199700449A1 (ru) 1998-06-25

Similar Documents

Publication Publication Date Title
ZA95556B (en) Combination treatment for osteoporosis
GB9508810D0 (en) Compounds
GB9500691D0 (en) Compounds
GB9504910D0 (en) Compounds
ZA964465B (en) Use of alendronate for the prevention of osteoporosis
GB9504948D0 (en) Compounds
GB9502540D0 (en) Compounds
IL117969A0 (en) Inhibiting photodecomposition of 3-substituted-2-oxinoles
IL110183A0 (en) Osteoporosis prevention apparatus
SI1175904T1 (sl) Alendronat za rabo pri zdravljenju osteoporoze
GB9521934D0 (en) Device for the location of fasteneres
AU131551S (en) Manhole components
GB9716883D0 (en) Combination therapy for the prevention and treatent of osteoporosis
GB9502785D0 (en) Compounds
GB9504990D0 (en) Compounds
GB9501580D0 (en) Compounds
GB9502782D0 (en) Compounds
GB9502783D0 (en) Compounds
GB9502784D0 (en) Compounds
GB9501471D0 (en) Compounds
GB9502983D0 (en) Compounds
GB9507313D0 (en) Compounds
GB9504190D0 (en) Compounds
GB9504802D0 (en) Compounds
GB9504803D0 (en) Compounds